ERG–TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin

Detection of TMPRSS2 Gene Deletions and Translocations in Carcinoma, Intraepithelial Neoplasia, and Normal Epithelium of the Prostate by Direct Fluorescence In Situ Hybridization

(2010) Shengle Zhang et al.   DIAGNOSTIC MOLECULAR PATHOLOGY

ERG rearrangement in small cell prostatic and lung cancer

(2010) Veit J Scheble et al.   HISTOPATHOLOGY

Multifocal prostate cancer: biologic, prognostic, and therapeutic implications

(2010) Matei Andreoiu et al.   HUMAN PATHOLOGY

TMPRSS2-ERG gene fusion in small cell carcinoma of the prostate☆

(2010) Charles C. Guo et al.   HUMAN PATHOLOGY

ERG rearrangement is present in a subset of transition zone prostatic tumors

(2010) Sara M Falzarano et al.   MODERN PATHOLOGY

ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor

(2010) Veit J Scheble et al.   MODERN PATHOLOGY

TMPRSS2–ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features

(2010) Samson W Fine et al.   MODERN PATHOLOGY

Prevalence of TMPRSS2–ERG and SLC45A3–ERG gene fusions in a large prostatectomy cohort

(2010) Raquel Esgueva et al.   MODERN PATHOLOGY

Small Cell Carcinoma of the Prostate

(2009) Wenle Wang et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

TMPRSS2-ERG Gene Fusion Is Not Associated with Outcome in Patients Treated by Prostatectomy

(2009) Anuradha Gopalan et al.   CANCER RESEARCH

Prevalence of TMPRSS2-ERG Fusion Prostate Cancer among Men Undergoing Prostate Biopsy in the United States

(2009) J.-M. Mosquera et al.   CLINICAL CANCER RESEARCH

TMPRSS2–ERG gene fusion status in minute (minimal) prostatic adenocarcinoma

(2009) Roula Albadine et al.   MODERN PATHOLOGY

Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma

(2009) Bo Han et al.   MODERN PATHOLOGY

Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate

(2009) Brett S Carver et al.   NATURE GENETICS

SharedTP53gene mutation in morphologically and phenotypically distinct concurrent primary small cell neuroendocrine carcinoma and adenocarcinoma of the prostate

(2009) Donna E. Hansel et al.   PROSTATE

Small Cell (Neuroendocrine) Carcinoma of the Prostate: Etiology, Diagnosis, Prognosis, and Therapeutic Implications—A Retrospective Study of 30 Patients From the Rare Cancer Network

(2008) Moshe E. Stein et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Characterization of TMPRSS2-ETS Gene Aberrations in Androgen-Independent Metastatic Prostate Cancer

(2008) R. Mehra et al.   CANCER RESEARCH

Characterization of TMPRSS2-ERG Fusion High-Grade Prostatic Intraepithelial Neoplasia and Potential Clinical Implications

(2008) J.-M. Mosquera et al.   CLINICAL CANCER RESEARCH

CD44 expression is a feature of prostatic small cell Carcinoma and Distinguishes it from its Mimickers

(2008) Rochelle A. Simon et al.   HUMAN PATHOLOGY

Cytopathology

(2008)   MODERN PATHOLOGY